Amrutanjan Health Care is currently trading at Rs. 590.10, up by 5.65 points or 0.97% from its previous closing of Rs. 584.45 on the BSE.
The scrip opened at Rs. 590.10 and has touched a high and low of Rs. 590.10 and Rs. 590.10 respectively. So far 19 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 790.00 on 15-May-2017 and a 52 week low of Rs. 517.00 on 21-Feb-2017.
Last one week high and low of the scrip stood at Rs. 620.00 and Rs. 579.85 respectively. The current market cap of the company is Rs. 894.00 crore.
The promoters holding in the company stood at 50.02%, while Institutions and Non-Institutions held 6.34% and 43.63% respectively.
Amrutanjan Health Care has emerged as the most trusted headache pain balm in India by ‘Economic Times Brand Equity Survey’ and the ranking has moved up from 134 in 2016 to 79 in 2017. Amrutanjan Balm is among the top 5 gainers across various categories in India. The company has been ranked 6th among OTC top 10 brands in India.
Amrutanjan Health Care is engaged in manufacturing Ayurvedic Pain Balms and Beverages. The company specializes in Ayurvedic balm for headaches, cold and cough.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1858.70 |
Dr. Reddys Lab | 1258.55 |
Cipla | 1559.20 |
Lupin | 2198.25 |
Zydus Lifesciences | 1004.00 |
View more.. |